Treace Medical Concepts, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -1.7%
EBITDA: -19.5%
EBIT: -6.6%
EPS: -14.4%
Free cash flow: +29.7%
Operating cash flow: +49.8%

Forward estimates

Revenue: +7.7%
EBITDA: +23.2%
EPS: +13.9%

Three-year CAGR

Revenue: +14.5%
EBITDA: -2.6%
EBIT: +2.8%
Net income: -5.8%
EPS: -3.3%
Free cash flow: +39.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.